These results imply that rhein alleviates hepatic lipid accumulation in NAFLD mice by activating the AMPK signaling pathway, thereby enhancing ACC phosphorylation and downregulating SREBP1 expression. The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.